Document
IPR2019-00690, No. 1054 Exhibit - Nalox1054 USP 36 NF 31 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1054 Exhibit - Nalox1054 USP 36 NF 31 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1042 Exhibit - Nalox1042 Monitto 2011 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1042 Exhibit - Nalox1042 Monitto 2011 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1056 Exhibit - Nalox1056 US Patent No 5,307,953 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1056 Exhibit - Nalox1056 US Patent No 5,307,953 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 2009 Exhibit - Opiant2009 FDA Teva Press Release (P.T.A.B. Jun. 11, 2019)
Cite Document
IPR2019-00690, No. 2009 Exhibit - Opiant2009 FDA Teva Press Release (P.T.A.B. Jun. 11, 2019)
+ More Snippets
Document
IPR2019-00690, No. 2027 Exhibit - Opiant2027 van Dorp 2007 (P.T.A.B. Jun. 11, 2019)
Cite Document
IPR2019-00690, No. 2027 Exhibit - Opiant2027 van Dorp 2007 (P.T.A.B. Jun. 11, 2019)
+ More Snippets
Document
IPR2019-00690, No. 2001 Exhibit - Opiant2001 Williams Decl (P.T.A.B. Jun. 11, 2019)
Cite Document
IPR2019-00690, No. 2001 Exhibit - Opiant2001 Williams Decl (P.T.A.B. Jun. 11, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1038 Exhibit - Nalox1038 Marple 2004 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1038 Exhibit - Nalox1038 Marple 2004 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1018 Exhibit - Nalox1018 APTAR Press Release (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1018 Exhibit - Nalox1018 APTAR Press Release (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1063 Exhibit - Nalox1063 Notice of Allowance from USP 9,468,747 FH (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1063 Exhibit - Nalox1063 Notice of Allowance from USP 9,468,747 FH (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1029 Exhibit - Nalox1029 2003 FDA Guidance (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1029 Exhibit - Nalox1029 2003 FDA Guidance (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 2021 Exhibit - Opiant2021 Sporer 1996 (P.T.A.B. Jun. 11, 2019)
Cite Document
IPR2019-00690, No. 2021 Exhibit - Opiant2021 Sporer 1996 (P.T.A.B. Jun. 11, 2019)
+ More Snippets
Document
IPR2019-00690, No. 2026 Exhibit - Opiant2026 Teva Case Schedule Stipulation (P.T.A.B. Jun. 11, 2019)
Cite Document
IPR2019-00690, No. 2026 Exhibit - Opiant2026 Teva Case Schedule Stipulation (P.T.A.B. Jun. 11, 2019)
+ More Snippets
Document
IPR2019-00690, No. 2015 Exhibit - Opiant2015 Loimer 1992 (P.T.A.B. Jun. 11, 2019)
Cite Document
IPR2019-00690, No. 2015 Exhibit - Opiant2015 Loimer 1992 (P.T.A.B. Jun. 11, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1026 Exhibit - Nalox1026 Costantino 2007 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1026 Exhibit - Nalox1026 Costantino 2007 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1001 Exhibit - Nalox1001 U S Patent 9,468,747 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1001 Exhibit - Nalox1001 U S Patent 9,468,747 (P.T.A.B. Feb. 19, 2019)
+ More Snippets